the relative risk for acute leukaemia following treatment with cyclophosphamide alone was significantly elevated ( p less than 0.05 ) , at 14.6 for ovarian tumour patients and 2.7 for breast cancer patients .
C0010583
cyclophosphamide
C0919267
ovarian tumour